Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Prepaid Assets (2016 - 2025)

Northwest Biotherapeutics (NWBO) has 16 years of Prepaid Assets data on record, last reported at $2.3 million in Q3 2025.

  • For Q3 2025, Prepaid Assets rose 3.28% year-over-year to $2.3 million; the TTM value through Sep 2025 reached $2.3 million, up 3.28%, while the annual FY2024 figure was $1.9 million, 5.6% down from the prior year.
  • Prepaid Assets reached $2.3 million in Q3 2025 per NWBO's latest filing, up from $1.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.7 million in Q1 2021 and bottomed at $1.7 million in Q3 2023.
  • Average Prepaid Assets over 5 years is $2.6 million, with a median of $2.3 million recorded in 2025.
  • The widest YoY moves for Prepaid Assets: up 102.96% in 2021, down 61.63% in 2021.
  • A 5-year view of Prepaid Assets shows it stood at $2.1 million in 2021, then rose by 15.98% to $2.5 million in 2022, then decreased by 18.74% to $2.0 million in 2023, then fell by 5.6% to $1.9 million in 2024, then rose by 23.32% to $2.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $2.3 million in Q3 2025, $1.8 million in Q2 2025, and $1.9 million in Q1 2025.